The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Nova Eye Medical (EYE) raises $8 million through a share placement to fund the expansion of its Glaucoma Surgical Devices in the US, Europe and China
  • The company issue 44.4 million new shares to existing and new institutional investors in two tranches to raise the funds
  • New shares to be issued under the placement will be priced at 18 cents — a 21.7 per cent discount to Nova’s last trading price on February 24
  • Company directors will subscribe for $270,000 of new shares as part of the placement, subject to shareholder approval
  • EYE shares are down 13.04 per cent to 20 cents at 2:41 pm AEDT

Nova Eye Medical (EYE) has raised $8 million through a two-tranche share placement to fund the expansion of its Glaucoma Surgical Devices in the US, Europe and China.

The company said the placement, which includes the issue of 44.4 million shares, was strongly supported by existing and new institutional investors.

The first tranche includes a total of 21,004,542 securities being offered to raise $3.78 million. Under the second tranche, Nova will issue the remaining 23,439,902 shares to raise $4.22 million.

Nova Eye Medical confirmed a capital raise price of 18 cents per new share, representing a 21.7 per cent discount to its last trading price on February 24, 2023.

The company said it expected new shares issued under the placement to settle on March 7 to commence trading on March 8.

Nova Eye Medical boasts a portfolio of propriety glaucoma treatment technologies that aim to enhance clinical outcomes and improve patient quality of life.

EYE shares were down 13.04 per cent to 20 cents at 2:41 pm AEDT.

EYE by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Bourse finishes week on a high as Wisetech pummeled | November 22, 2024

The ASX200 closed up 0.85% at 8,393 points. Economists increasingly expect interest rates in Australia won’t…
The Market Online Video

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing,…
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…